The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today ...

Shire itself was a proponent of this strategy ... the average drug has now more than doubled to $2 billion and pharma companies need scale to ensure they can deal with expensive failures, while ...

It's not every company that can go from $7 million in revenues to more than $1.7 billion in 10 years, but that's precisely what Shire Pharmaceuticals, whose hub lies in Wayne, Pa., accomplished in the ...

Shire Pharmaceuticals has announced it will ... In this respect, Teva could be seen more as a specialty pharma company than a generics maker. Stephen Kaldor, president and CEO of the biotech ...

Before joining Galderma, Ornskov was CEO of pharma company Shire from 2013 to 2019. If approved by the FDA, the company expects to start rolling out atopic dermatitis drug in early 2025 and ...

When we welcomed Shire employees into Takeda ... Insider: Looking forward, how do you see the pharmaceutical company of the future? Weber: Highly scientific. Highly innovative.

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company ... the town of Shire in Ethiopia's ...

For the first time, the quarterly 'Double Up' stock screen has failed to beat its benchmark ...

TOKYO (Reuters) -Takeda Pharmaceutical said on Thursday ... the first woman to head Takeda, joined the company in 2019 along with the acquisition of Shire. She was the head of Takeda's plasma ...